ABVC BioPharma, Inc. Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised
ABVC BioPharma, Inc. (ABVC) reported Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised of $493.48 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans · last filed 2021-08-12
- 2020-06-30: Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 6 month $493.48K.
| Period end | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 6 month |
|---|---|
| 2020-06-30 | $493.48K 10-Q · filed 2021-08-12 |